D

Deciphera Pharmaceuticals Inc
F:D05

Watchlist Manager
Deciphera Pharmaceuticals Inc
F:D05
Watchlist
Price: 42.78 EUR 0.07% Market Closed
Market Cap: 3.5B EUR
Have any thoughts about
Deciphera Pharmaceuticals Inc?
Write Note

Deciphera Pharmaceuticals Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Deciphera Pharmaceuticals Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
D
Deciphera Pharmaceuticals Inc
F:D05
Free Cash Flow
-$152.4m
CAGR 3-Years
13%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$15.6B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$10B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$6.3B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.3B
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
20%

See Also

What is Deciphera Pharmaceuticals Inc's Free Cash Flow?
Free Cash Flow
-152.4m USD

Based on the financial report for Mar 31, 2024, Deciphera Pharmaceuticals Inc's Free Cash Flow amounts to -152.4m USD.

What is Deciphera Pharmaceuticals Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-8%

Over the last year, the Free Cash Flow growth was 0%. The average annual Free Cash Flow growth rates for Deciphera Pharmaceuticals Inc have been 13% over the past three years , -8% over the past five years .

Back to Top